bioSyntagma Company

bioSyntagma develops molecular fingerprint for diagnosing and discovering disease.
Technology: Biotechnology, Life Science
Industry: Clinical Development, Data Processing
Headquarters: Phoenix, Arizona, United States
Founded Date: 2015-04-02
Employees Number: 1-10
Investors Number: 2
Total Funding: 1382086
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-03-19
Last Funding Type: Grant

Visit Website
Register and Claim Ownership